193 related articles for article (PubMed ID: 9470172)
1. Stereochemistry-dependent inhibition of RAS farnesylation by farnesyl phosphonic acids.
Hohl RJ; Lewis KA; Cermak DM; Wiemer DF
Lipids; 1998 Jan; 33(1):39-46. PubMed ID: 9470172
[TBL] [Abstract][Full Text] [Related]
2. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
[TBL] [Abstract][Full Text] [Related]
3. 2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase.
Trotter BW; Quigley AG; Lumma WC; Sisko JT; Walsh ES; Hamann CS; Robinson RG; Bhimnathwala H; Kolodin DG; Zheng W; Buser CA; Huber HE; Lobell RB; Kohl NE; Williams TM; Graham SL; Dinsmore CJ
Bioorg Med Chem Lett; 2001 Apr; 11(7):865-9. PubMed ID: 11294379
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of farnesyl-protein-transferase in neuroblastoma cells by alpha-hydroxyfarnesylphosphonate.
Girgert R; Hohnecker A; Wittrock J; Schweizer P
Anticancer Res; 1999; 19(4B):2959-62. PubMed ID: 10652579
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
[TBL] [Abstract][Full Text] [Related]
6. Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein:farnesyltransferase to different extents.
Cohen LH; Valentijn AR; Roodenburg L; Van Leeuwen RE; Huisman RH; Lutz RJ; Van der Marel GA; Van Boom JH
Biochem Pharmacol; 1995 Mar; 49(6):839-45. PubMed ID: 7702642
[TBL] [Abstract][Full Text] [Related]
7. Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.
Kothapalli R; Guthrie N; Chambers AF; Carroll KK
Lipids; 1993 Nov; 28(11):969-73. PubMed ID: 8277827
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of a transferable farnesyl pyrophosphate analogue to Ras by protein farnesyltransferase.
Chehade KA; Andres DA; Morimoto H; Spielmann HP
J Org Chem; 2000 May; 65(10):3027-33. PubMed ID: 10814193
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of prenyl alcohols by terpenoid biosynthesis inhibitors in various microorganisms.
Muramatsu M; Ohto C; Obata S; Sakuradani E; Shimizu S
Appl Microbiol Biotechnol; 2008 Sep; 80(4):589-95. PubMed ID: 18636253
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.
Gibbs JB; Pompliano DL; Mosser SD; Rands E; Lingham RB; Singh SB; Scolnick EM; Kohl NE; Oliff A
J Biol Chem; 1993 Apr; 268(11):7617-20. PubMed ID: 8463291
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.
Perez M; Maraval C; Dumond S; Lamothe M; Schambel P; EtiƩvant C; Hill B
Bioorg Med Chem Lett; 2003 Apr; 13(8):1455-8. PubMed ID: 12668011
[TBL] [Abstract][Full Text] [Related]
12. J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive manner.
Yonemoto M; Satoh T; Arakawa H; Suzuki-Takahashi I; Monden Y; Kodera T; Tanaka K; Aoyama T; Iwasawa Y; Kamei T; Nishimura S; Tomimoto K
Mol Pharmacol; 1998 Jul; 54(1):1-7. PubMed ID: 9658183
[TBL] [Abstract][Full Text] [Related]
13. Protein farnesyltransferase inhibitors interfere with farnesyl diphosphate binding by rubber transferase.
Mau CJ; Garneau S; Scholte AA; Van Fleet JE; Vederas JC; Cornish K
Eur J Biochem; 2003 Oct; 270(19):3939-45. PubMed ID: 14511375
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human smooth muscle cell proliferation in culture by farnesyl pyrophosphate analogues, inhibitors of in vitro protein: farnesyl transferase.
Cohen LH; Pieterman E; van Leeuwen RE; Du J; Negre-Aminou P; Valentijn AR; Overhand M; van der Marel GA; van Boom JH
Biochem Pharmacol; 1999 Feb; 57(4):365-73. PubMed ID: 9933024
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory activity to protein prenylation and antifungal activity of zaragozic acid D3, a potent inhibitor of squalene synthase produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Ohya S; Tsujita Y
J Antibiot (Tokyo); 1998 Apr; 51(4):428-31. PubMed ID: 9630865
[TBL] [Abstract][Full Text] [Related]
16. Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase.
Holstein SA; Cermak DM; Wiemer DF; Lewis K; Hohl RJ
Bioorg Med Chem; 1998 Jun; 6(6):687-94. PubMed ID: 9681134
[TBL] [Abstract][Full Text] [Related]
17. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors.
Whyte DB; Kirschmeier P; Hockenberry TN; Nunez-Oliva I; James L; Catino JJ; Bishop WR; Pai JK
J Biol Chem; 1997 May; 272(22):14459-64. PubMed ID: 9162087
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics.
Cohen LH; Pieterman E; van Leeuwen RE; Overhand M; Burm BE; van der Marel GA; van Boom JH
Biochem Pharmacol; 2000 Oct; 60(8):1061-8. PubMed ID: 11007942
[TBL] [Abstract][Full Text] [Related]
20. Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
Nagase T; Kawata S; Tamura S; Matsuda Y; Inui Y; Yamasaki E; Ishiguro H; Ito T; Miyagawa J; Mitsui H; Yamamoto K; Kinoshita M; Matsuzawa Y
Br J Cancer; 1997; 76(8):1001-10. PubMed ID: 9376258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]